GILD
vs
BMY
GILD
BMY
Over the past 12 months, GILD has significantly outperformed BMY, delivering a return of +26% compared to the BMY's +1% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
GILD
BMY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Gilead Sciences Inc
NASDAQ:GILD
|
144.775
USD
|
|||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
60.705
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
GILD, BMY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Gilead Sciences Inc
Revenue
|
|||||||||||
|
Bristol-Myers Squibb Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
GILD, BMY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Gilead Sciences Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Gilead Sciences Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Gilead Sciences Inc | ||||
|
Bristol-Myers Squibb Co | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Gilead Sciences Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
GILD, BMY
Performance By Year
GILD, BMY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|